Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Medicine before and after David Cox.

Pavlos Msaouel1, Paula Jimenez-Fonseca2, Bora Lim3

  • 1Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, United States of America.

European Journal of Internal Medicine
|March 4, 2022
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LIG1 Loss in TP53-mutant Triple Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP-ATR Inhibitor Combinations.

Molecular cancer therapeutics·2026
Same author

Angiotensin system inhibitors as adjunctive therapy in esophageal adenocarcinoma: hypothesis-generating insights from incidental use during trimodal treatment.

Translational cancer research·2026
Same author

Proximal-to-distal gradient and its implications in differentiation and prognosis in colorectal neuroendocrine neoplasms: the RGETNE-HERACLES study.

Neuroendocrinology·2026
Same author

Scientific highlights and perspectives from the International Inflammatory Breast Cancer Symposium 2025.

Cancer·2026
Same author

Ecotypes of triple-negative breast cancer in response to chemotherapy.

Nature·2026
Same author

The ARTEMIS trial identifies immune activation as a key predictor of neoadjuvant chemotherapy response in triple-negative breast cancer.

Breast cancer research : BCR·2026

Sir David Cox

Area of Science:

  • Biostatistics and Epidemiology
  • Clinical Research Methodology

Background:

  • Sir David Cox's groundbreaking work introduced logistic regression and Cox proportional hazards models.
  • These statistical methods transformed the analysis of categorical and time-to-event data.

Discussion:

  • Clinicians widely adopted Cox's models, revolutionizing medical research and clinical decision-making.
  • His contributions significantly advanced the interpretation of survival outcomes in various medical fields.

Key Insights:

  • The logistic regression model remains fundamental for analyzing binary outcomes.
  • Cox proportional hazards models are indispensable for time-to-event analysis in clinical trials.

Outlook:

  • Sir David Cox's legacy continues to inspire statisticians and clinicians.
Keywords:
Binary logistic regressionDavid CoxDavid coxHistoryProportional hazards modelsurvival analysis

Related Experiment Videos

  • Ongoing research builds upon his foundational work in statistical modeling for medicine.